Showing 4101-4110 of 9578 results for "".
- CDC Awards Grant to National Eczema Associationhttps://practicaldermatology.com/news/cdc-awards-grant-to-national-eczema-association/2462047/The National Eczema Association (NEA) was recently awarded a grant from the Centers for Disease Control and Pre
- Crown Therapeutics Rolls Out PanOxyl Clarifying Exfoliant, PanOxyl Adapalene 0.1% Gelhttps://practicaldermatology.com/news/crown-therapeutics-rolls-out-panoxyl-clarifying-exfoliant-panoxyl-adapalene-01-gel/2462039/Crown Therapeutics is launching two new PanOxyl products: PanOxyl Clarifying Exfoliant with 2% Salicylic Acid and PanOxyl Adapalene 0.1% Gel. PanOxyl Clarifying Exfoliant features a pH-balanced, alcohol-free formula that can be used daily without any harsh
- Wound Repair Breakthrough: Protein Coacervates Engineered Into Adhesive for “Unprecedented” Skin Repair Speedhttps://practicaldermatology.com/news/wound-repair-breakthrough-protein-coacervates-engineered-into-adhesive-for-unprecedented-skin-repair-speed/2462032/A team of researchers from China is developing a novel biocomposite adhesive that may revolutionize wound management and tissue repair, according to a study in Engineering.
- Scrubbing Behind the Ears and Between the Toes May Help Keep These Skin Areas Healthyhttps://practicaldermatology.com/news/scrubbing-behind-the-ears-and-between-the-toes-may-help-keep-this-skin-healthy/2462030/Skin behind the ears and between the toes can host a collection of unhealthy microbes, according to a new study by a team at the George Washington University. Researchers at the GW Computational Biology Institute wanted to take a closer look at the skin microbiome of healthy
- NEA Launches #OneThingAboutEczema Campaign for Eczema Awareness Monthhttps://practicaldermatology.com/news/nea-launches-onethingabouteczema-campaign-for-eczema-awareness-month/2462029/The National Eczema Association (NEA) is highlighting different aspects of living with eczema for its annua
- AD News: Lebrikizumab Clears Hurdle in EUhttps://practicaldermatology.com/news/ad-news-lebrikizumab-clears-hurdle-in-eu/2462005/The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Almirall's EBGLYSS (lebrikizumab) for the treatment of adult and adolescent patients aged 12 and older with a body weight of at least 40 kg who have moderate
- A Livestock Drug Delivered Via Nanoparticles May Help Eradicate Acnehttps://practicaldermatology.com/news/a-livestock-drug-delivered-via-nanoparticles-may-help-eradicate-acne/2462004/Australian scientists may have found an effective treatment for acne that is delivered via tiny nanoparticles. In a study led by the
- Almirall Launches New Campaign, Atopic Museum for World Eczema Dayhttps://practicaldermatology.com/news/almirall-launches-new-campaign-atopic-museum-for-world-eczema-day/2462003/Almirall unveiled its atopic dermatitis awareness campaign "Moving aheAD" for World Atopic Eczema Day. The campaign includes the “Atopic M
- Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co. Ltd. for Qbrexza in South Korea, Other Asian Nationshttps://practicaldermatology.com/news/journey-medical-corporation-enters-into-an-exclusive-license-agreement-with-maruho-co-ltd-for-qbrexza-in-south-korea-other-asian-nations/2461983/Journey Medical Corporation has entered into an exclusive license agreement with Maruho Co., Ltd. for Qbrexza in South Korea and Other Asian Nations. Maruho Co., Ltd. is Journey’s exclusive licensing partner that developed and is commercializing Qbrexza (Rapifort) in Japan.&n
- Nathalie Daste Named LEO Pharma’s New Executive Vice President of Global People and Corporate Affairshttps://practicaldermatology.com/news/nathalie-daste-named-leo-pharmas-new-executive-vice-president-of-global-people-and-corporate-affairs/2461964/Nathalie Daste is LEO Pharma’s new Executive Vice President, Global People and Corporate Affairs, and member of its Global Leadership Team, effective October 1, 2023. In her new role, Ms. Daste will head LEO Pharma’s Global People function as well as Corporate Affa